MedPath
Found 549959 clinical trials
Sort by:

"Effects of Rigid Tape in Patients With Chronic Achilles Tendinopathy"

Not Applicable
Not yet recruiting
Conditions
Achilles Tendinopathy (AT)
First Posted Date
2025-08-14
Last Posted Date
2025-08-19
Lead Sponsor
University of Gran Rosario
Target Recruit Count
36
Registration Number
NCT07123246

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Not Applicable
Recruiting
Conditions
Non-Hodgkin Lymphoma Refractory/ Relapsed
DLBCL - Diffuse Large B Cell Lymphoma
Mantle Cell Lymphoma (MCL)
Follicular Lymphoma ( FL)
Marginal Zone Lymphoma (MZL)
Interventions
First Posted Date
2025-08-14
Last Posted Date
2025-08-19
Lead Sponsor
LTZ Therapeutics, Inc.
Target Recruit Count
42
Registration Number
NCT07121946
Locations
🇺🇸

Tennessee Oncology, Nashville, Tennessee, United States

The Effect of Art-Based Nursing Intervention Helping to Develop Healthy Digital Habits on Digital Addiction, Cyberbullying and Self-Efficacy in Adolescents

Not Applicable
Not yet recruiting
Conditions
Digital Addiction
Cyberbullying
Art Therapy
Self Efficacy
Adolescence
First Posted Date
2025-08-14
Last Posted Date
2025-08-19
Lead Sponsor
Selcuk University
Target Recruit Count
64
Registration Number
NCT07123194

Comparison of the Postoperative Analgesic Effects of ITM and Bi-level ESPB in Liver Transplantation Donors

Not Applicable
Recruiting
Conditions
Liver Transplantation
Pain Management
First Posted Date
2025-08-14
Last Posted Date
2025-08-19
Lead Sponsor
Ankara Etlik City Hospital
Target Recruit Count
60
Registration Number
NCT07123740
Locations
🇹🇷

Ankara Etlik City Hospital, Altındağ, Ankara, Turkey

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

Not Applicable
Not yet recruiting
Conditions
Systemic Lupus Erythematosus (SLE)
Inflammatory Myopathy
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Lupus Nephritis (LN)
Sjogren's Syndrome (SS)
Antiphospholipid Syndrome (APS)
Interventions
Drug: YTS109 cell
First Posted Date
2025-08-14
Last Posted Date
2025-08-19
Lead Sponsor
China Immunotech (Beijing) Biotechnology Co., Ltd.
Target Recruit Count
18
Registration Number
NCT07123519
Locations
🇨🇳

Institute of Hematology & Blood Diseases Hospital, China, Tianjin, China

Prevention of Hospital Acquired Deconditioning in Hospitalized Acute Leukemia Patients

Not Applicable
Active, not recruiting
Conditions
Acute Leukemia
First Posted Date
2025-08-14
Last Posted Date
2025-08-19
Lead Sponsor
Northwell Health
Target Recruit Count
50
Registration Number
NCT07122479
Locations
🇺🇸

North Shore University Hospital (NSUH), Manhasset, New York, United States

🇺🇸

Zuckerberg Cancer Center, New Hyde Park, New York, United States

Alleviating Loneliness in Older Adults Living in Poverty: A Multi-level Intervention

Not Applicable
Not yet recruiting
Conditions
Loneliness
Poverty
First Posted Date
2025-08-14
Last Posted Date
2025-08-19
Lead Sponsor
Education University of Hong Kong
Target Recruit Count
1344
Registration Number
NCT07123064
Locations
🇭🇰

The Education University of Hong Kong, Hong Kong, Hong Kong

Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease

Not yet recruiting
Conditions
Inflammatory Bowel Disease (IBD)
Crohn&Amp;#39;s Disease (CD)
Ulcerative Colitis (UC)
Interventions
Drug: Patient switched from IV vedolizumab to subcutaneous vedolizumab as part of normal patient care
First Posted Date
2025-08-14
Last Posted Date
2025-08-19
Lead Sponsor
Vanderbilt University Medical Center
Target Recruit Count
120
Registration Number
NCT07123350
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

Not Applicable
Recruiting
Conditions
HIV
Hepatitis C Virus (HCV)
First Posted Date
2025-08-14
Last Posted Date
2025-08-19
Lead Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Target Recruit Count
548
Registration Number
NCT07122219
Locations
🇨🇦

Edmonton Institution for Women, Edmonton, Alberta, Canada

🇨🇦

Fraser Valley Institution for Women, Abbotsford, British Columbia, Canada

🇨🇦

Mission Institution, Mission, British Columbia, Canada

and more 6 locations

Serum 25-Hydroxyvitamin D and Neurological Disability in Multiple Sclerosis

Completed
Conditions
Multiple Sclerosis
First Posted Date
2025-08-14
Last Posted Date
2025-08-19
Lead Sponsor
University of Zintan
Target Recruit Count
369
Registration Number
NCT07123337
Locations
🇱🇾

Faculty of medicine zintan university, Tripoli, Libyan Arab Jamahiriya

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.